The store will not work correctly when cookies are disabled.
4-(4-((2,6-dichloro-9H-purin-9-yl)methyl)-1H-1,2,3-triazol-1-yl)-1H-chromen-2-one
ID: ALA4525080
PubChem CID: 155538774
Max Phase: Preclinical
Molecular Formula: C17H9Cl2N7O2
Molecular Weight: 414.21
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1cc(-n2cc(Cn3cnc4c(Cl)nc(Cl)nc43)nn2)c2ccccc2o1
Standard InChI: InChI=1S/C17H9Cl2N7O2/c18-15-14-16(22-17(19)21-15)25(8-20-14)6-9-7-26(24-23-9)11-5-13(27)28-12-4-2-1-3-10(11)12/h1-5,7-8H,6H2
Standard InChI Key: HOCQXHRVVWEATN-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
3.9745 -6.1009 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3822 -5.3928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1923 -5.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2740 -6.3715 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5223 -6.6980 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7722 -5.0016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5600 -5.2137 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1357 -4.6339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8711 -5.0243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7455 -5.8094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9334 -5.9317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5795 -4.5733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5412 -3.7442 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8058 -3.3630 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1015 -3.8073 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8058 -2.5435 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
9.2876 -4.9851 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.1623 -6.1906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5413 -6.3672 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0241 -7.0277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8393 -6.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8738 -5.6203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6801 -5.5332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0060 -4.7955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5296 -4.1400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7233 -4.2270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3934 -4.9697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6931 -7.7748 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 2 0
3 4 1 0
5 4 2 0
1 5 1 0
3 6 1 0
6 7 1 0
8 7 1 0
8 9 2 0
9 10 1 0
11 10 2 0
7 11 1 0
9 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
8 15 1 0
14 16 1 0
12 17 1 0
1 18 1 0
18 23 1 0
18 21 2 0
22 19 1 0
19 20 1 0
20 21 1 0
22 23 1 0
22 27 2 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
20 28 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 414.21 | Molecular Weight (Monoisotopic): 413.0195 | AlogP: 2.87 | #Rotatable Bonds: 3 |
Polar Surface Area: 104.52 | Molecular Species: NEUTRAL | HBA: 9 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.53 | CX LogD: 2.53 |
Aromatic Rings: 5 | Heavy Atoms: 28 | QED Weighted: 0.25 | Np Likeness Score: -1.15 |
References
1. Zhao JW, Wu ZH, Guo JW, Huang MJ, You YZ, Liu HM, Huang LH.. (2019) Synthesis and anti-gastric cancer activity evaluation of novel triazole nucleobase analogues containing steroidal/coumarin/quinoline moieties., 181 [PMID:31404863] [10.1016/j.ejmech.2019.07.023] |